MUNARI, GIADA
 Distribuzione geografica
Continente #
NA - Nord America 1.735
AS - Asia 301
EU - Europa 177
OC - Oceania 3
SA - Sud America 3
Totale 2.219
Nazione #
US - Stati Uniti d'America 1.733
CN - Cina 138
SG - Singapore 81
IT - Italia 64
HK - Hong Kong 59
SE - Svezia 29
DE - Germania 19
FR - Francia 18
FI - Finlandia 16
VN - Vietnam 15
GB - Regno Unito 11
RU - Federazione Russa 7
IN - India 5
ES - Italia 4
AU - Australia 3
NL - Olanda 3
CA - Canada 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
PK - Pakistan 2
BR - Brasile 1
IE - Irlanda 1
PH - Filippine 1
UA - Ucraina 1
Totale 2.219
Città #
Fairfield 335
Chandler 191
Ashburn 146
Seattle 141
Woodbridge 129
Cambridge 120
Houston 118
Wilmington 84
Ann Arbor 73
Singapore 67
Santa Clara 41
Beijing 37
Boardman 33
San Diego 32
Medford 24
Princeton 24
Padova 20
Helsinki 16
Des Moines 13
Dong Ket 13
New York 12
Roxbury 10
Nanjing 8
Hefei 5
Los Angeles 5
Shanghai 5
Shenyang 5
Guangzhou 4
Moscow 4
Nanchang 4
Paris 4
Arzignano 3
Changsha 3
Córdoba 3
Hebei 3
Jiaxing 3
Jinan 3
Kunming 3
London 3
Milan 3
Ogden 3
Zhengzhou 3
Dallas 2
Florence 2
Hnevotin 2
Ho Chi Minh City 2
Kilburn 2
Ningbo 2
Pune 2
Rovereto 2
Santiago 2
Suzhou 2
Sydney 2
Taizhou 2
Terni 2
Bassano del Grappa 1
Brendola 1
Calgary 1
Castelbellino 1
Chambray-lès-Tours 1
Changchun 1
Chengdu 1
Chicago 1
Council Bluffs 1
Dolo 1
Dublin 1
Erding 1
Ferrara 1
Filadelfia 1
Fontenay-sous-bois 1
Gunzenhausen 1
Haikou 1
Hanover 1
Indore 1
Islamabad 1
Kaifeng 1
Kharkiv 1
Little Elm 1
Manila 1
Mardan 1
Modica 1
New Bedfont 1
Nuremberg 1
Phoenix 1
Quzhou 1
Rockville 1
Salerno 1
Shantou 1
São Paulo 1
Taiyuan 1
Tappahannock 1
Turin 1
Venice 1
Wandsworth 1
Washington 1
Wenzhou 1
Totale 1.823
Nome #
Class 1, 2 and 3 BRAF mutated metastatic colorectal cancer: a detailed clinical, pathological and molecular characterization 178
Molecular characterization of “sessile serrated” adenoma to carcinoma transition in six early colorectal cancers 146
Thyroid-like follicular carcinoma of the kidney: The mutational profiling reveals a BRAF wild type status 121
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa 120
Clear cell dysplasia in a sessile serrated adenoma 118
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 115
Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions 113
Adenosquamous carcinoma of the papilla of Vater: A phenotypic heterogeneity characterized by a common molecular landscape 112
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases 110
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis 110
Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITA 109
Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study 104
Mutational and immunophenotypic profiling of a series of 8 tubo-ovarian carcinosarcomas revealed a monoclonal origin of the disease 100
Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver 98
Low-grade neuroepithelial tumor: Unusual presentation in an adult without history of seizures 91
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer 84
mTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs 80
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience 62
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes 53
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases 48
A real-world application of liquid biopsy in metastatic colorectal cancer: The poseidon study 44
FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint 34
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 30
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling 29
Molecular determinants of peritoneal dissemination in gastric adenocarcinoma 26
TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by NTRK Fusions 17
Totale 2.252
Categoria #
all - tutte 10.054
article - articoli 10.054
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020303 0 0 0 0 0 31 66 59 59 45 26 17
2020/2021337 20 27 8 22 25 12 23 33 47 48 47 25
2021/2022409 33 34 49 9 36 38 23 30 24 28 27 78
2022/2023389 56 49 5 48 39 34 6 24 97 9 19 3
2023/2024217 6 39 20 18 21 27 19 9 11 16 13 18
2024/2025226 4 52 38 19 81 32 0 0 0 0 0 0
Totale 2.252